English
Home > Products > Travoprost API

China Travoprost API Factory

Bear "Customer very first, Quality first" in mind, we work closely with our customers and supply them with efficient and professional services for Travoprost API,CAS NO:157283-68-6,Travoprost, We have been self-assured to make excellent achievements within the future. We've been looking forward to becoming one within your most trusted suppliers.
Travoprost API, We have been always creating new technology to streamline the production, and offer goods with competitive prices and high quality! Customer satisfaction is our priority! You can let us know your idea to develop unique design for your own model to prevent too much similar parts in the market! We'll offer you our best service to satisfy all your needs! Be sure to contact us right away!

Related Products

Hot Products

  • 1-Boc-3-Iodoazetidine

    1-Boc-3-Iodoazetidine

    Product Name:1-Boc-3-Iodoazetidine
    Molecular Formula:C8H14INO2
    Molecular Weight:283.11
    CAS Registry Number:254454-54-1
  • Tenofovir

    Tenofovir

    Product Name:Tenofovir
    Molecular Formula:C9H14N5O4P
    Molecular Weight:287.21
    CAS Registry Number:147127-20-6
  • 2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole

    2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole

    Product Name:2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole
    Molecular Formula:C7H11N3S
    Molecular Weight:169.25
    CAS Registry Number:104617-49-4
  • Larotrectinib sulfate

    Larotrectinib sulfate

    Product Name:Larotrectinib sulfate
    Molecular Formula:C21H24F2N6O6S
    Molecular Weight;526.52
    CAS Registry Number;1223405-08-0
  • L(-)-Pipecolinic acid

    L(-)-Pipecolinic acid

    Product Name:L(-)-Pipecolinic acid
    Molecular Formula:C6H11NO2
    Molecular Weight:129.16
    CAS Registry Number:3105-95-1
  • L-Aspartic acid

    L-Aspartic acid

    Product Name:L-Aspartic acid
    Molecular Formula:C4H7NO4
    Molecular Weight;133.1
    CAS Registry Number;56-84-8
  • Related Blog
  • Reviews

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept